The big news in the biotech sector this week is the acquisition agreement under which Japanese firm Takeda will be acquiring cancer-focused ARIAD ARIA for a whopping $5.2 billion. Several other licensing deals and agreements were …
High-flying biotech Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) was called out for its rapid drug price raises today by Senator Bernie Sanders, and its stock quickly crashed as a result. Since the beginning of the year, the company …
ARIA stock had traded over $20 a share in September, but ARIA stock plunged in October after the U.S. Food and Drug Administration halted a trial of its anti-cancer treatment, Iclusig, after some patients developed blood clots. The buyers …
Bump stock manufacturers under fire The Justice Department said ... (Madison Miller/Las Vegas Review-Journal Correspondent) Suspected Aria counterfeiter …
Once again, a single tweet on drug pricing resulted in weakness in the biotech sector with ARIAD ARIA losing ground …
One stock that might be an intriguing choice for investors right now is Ariad Pharmaceuticals Inc. ( ARIA). This is because this security in the Medical-Drugs is seeing solid earnings estimate revision activity, and is in great company from a …
Bump stock manufacturers under fire The Justice Department said ... (Madison Miller/Las Vegas Review-Journal Correspondent) Suspected Aria counterfeiter …
Ariad Pharmaceuticals.Inc ARIA was a big mover last session, as the company saw its shares rise by over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses …